Dabur Research Foundation - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U73100DL1979NPL010092 Incorporated 24 December 1979 ROC Delhi HQ New Delhi, Delhi, India
Active Public Not For Profit Company pharma
Data last updated
Revenue · FY 2025
₹28.06 Cr
▲ 34% YoY
Net profit · FY 2025
₹1.58 Cr
Net margin 5.6%
EBITDA · FY 2025
₹5.28 Cr
EBITDA margin 18.8%
Company age
47 yrs
Est. 1979
Employees · EPFO
115
Provident fund records
Directors on board
5
As per MCA filings
Active GSTINs
2
GST registered
Brands
1
Associated brands

About Dabur Research Foundation

Data last updated:

Dabur Research Foundation is a public not for profit company based in New Delhi, Delhi, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 24 December 1979 and has been in existence for over 47 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U73100DL1979NPL010092. Its GSTIN is 07AAATD2653G1ZZ (Delhi). The company holds 2 GST registrations, all of them active.

It is led by directors including Pradip Burman and Gaurav Chamaria.

Its last annual general meeting (AGM) was held on 18 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 8/3 Asaf Ali Road, New Delhi, Delhi, India – 110002.

As per the financials filed for FY 2025, the company reported a revenue of ₹28.06 Cr, a growth of 34% compared to the previous year. For the same year it recorded a net profit of ₹1.58 Cr (net margin 5.6%) and EBITDA of ₹5.28 Cr (EBITDA margin 18.8%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 6% over five years.

The company has about 115 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Dabur Research.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website daburresearch.in.

Company Details of Dabur Research Foundation
CIN U73100DL1979NPL010092
Registration Number 010092
Incorporation Date 24 December 1979
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 18 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    8/3 Asaf Ali Road, New Delhi, Delhi, India – 110002
  • Industry
    Pharma, Pharma Contract R&D
Comprehensive company report
Dabur Research Foundation - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Dabur Research Foundation report

Financials, compliance, directors, charges, ownership and filings for Dabur Research Foundation in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Dabur Research Foundation

The main business activity of Dabur Research Foundation is professional, scientific and technical. In detail, this covers scientific research and development.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
MProfessional, Scientific and TechnicalM5Scientific research and developmentLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Dabur Research Foundation FY 2025 filings available

Dabur Research Foundation reported revenue of ₹28.06 Cr (up 34% YoY) for FY 2025.

Revenue · FY 2025
₹28.06 Cr ▲ 34%
Net profit · FY 2025
₹1.58 Cr margin 5.6%
EBITDA · FY 2025
₹5.28 Cr margin 18.8%

Compounded Annual Growth Rate (CAGR) of Dabur Research Foundation

Revenue CAGR growth
1 year
▲ 34%
3 years · compounded
▲ 3%
5 years · compounded
▲ 6%
EBITDA CAGR growth
3 years · compounded
▲ 135%
5 years · compounded
▲ 19%

Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 34% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Dabur Research Foundation

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹5.28 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹1.58 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Dabur Research Foundation

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin18.8%••••••••••••••••
Net Profit Margin5.6%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dabur Research Foundation are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Dabur Research Foundation

Dabur Research Foundation is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
FTF Pharma Private Limited₹29.49 Cr (FY 2025)••••••••12.0%••••Ahmedabad, Gujarat, India
Clinical Research Network India Private Limited₹29.26 Cr (FY 2024)••••••••-30.0%••••Hyderabad, Telangana, India
Advity Research Private Limited₹28.98 Cr (FY 2025)••••••••35.0%••••Hyderabad, Telangana, India
Lifeline Services Private Limited₹28.45 Cr (FY 2015)••••••••-46.0%••••Delhi, India
Xellia Pharmaceuticals Private Limited₹28.32 Cr (FY 2025)••••••••16.0%••••Bangalore, Karnataka, India
Dabur Research Foundation this company₹28.06 Cr (FY 2025)••••••••34.0%••••New Delhi, Delhi, India
Innoxel Lifesciences Private Limited₹27.98 Cr (FY 2025)••••••••648.0%••••Vadodara, Gujarat, India
Bhat Bio-Tech India Private Limited₹27.36 Cr (FY 2025)••••••••92.0%••••Bangalore, Karnataka, India
Therdose Pharma Private Limited₹26.66 Cr (FY 2025)••••••••12.0%••••Hyderabad, Telangana, India
Vedic Lifesciences Private Limited₹26.36 Cr (FY 2025)••••••••20.0%••••Mumbai, Maharashtra, India
Bugworks Research India Private Limited₹25.18 Cr (FY 2025)••••••••-12.0%••••Bangalore, Karnataka, India

Peers are the five companies nearest above and the five nearest below Dabur Research Foundation by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Dabur Research Foundation

Dabur Research Foundation is audited by S.N. Dhawan & Co LLP for the financial year 2023.

NameStatusAppointment DateCessation Date
S.N. Dhawan & Co LLPLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Dabur Research Foundation

Dabur Research Foundation has 5 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors

Ownership and Shareholding of Dabur Research Foundation

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Dabur Research Foundation

Dabur Research Foundation does not have any charges (loans) registered with the Registrar of Companies.

MSME Payment Delays by Dabur Research Foundation

Dabur Research Foundation has 11 MSME Form 1 returns on record between 2020 and 2023, listing 1,188 overdue payments to 53 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 53)

SupplierAmount dueDue sinceReported on
Graphstats Technologies Private Limited••••••••••••
an individual supplier••••••••••••
K N Life Science••••••••••••
Macflow Engineering Private Limited••••••••••••
Del-Tech Instruments Private Limited••••••••••••
Premium access

Full MSME payment history

Every supplier, amount and due date from all 11 MSME Form 1 returns is in the company report.

  • Every reported supplier due
  • Amounts and due dates
  • Reasons given in each return
  • Period-by-period history

Verified entity values are shown only after access is granted.

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Associated Brands with Dabur Research Foundation

Dabur Research Foundation operates one associated brand: Dabur Research. Each brand links to its own profile.

BrandDescriptionWebsite
Offers preclinical studies, toxicology, discovery services, and consulting for pharmaceutical development.daburresearch.in

Employees and EPFO Compliance at Dabur Research Foundation

Dabur Research Foundation has a workforce of 115 employees as of Apr 08, 2024.

Employee count
115
Active EPFO establishments
1
Employee growth
-1.71%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

CIN History of Dabur Research Foundation

Dabur Research Foundation has one previous CIN (Corporate Identification Number): U73100DL1979PTC010092. The current CIN is U73100DL1979NPL010092, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U73100DL1979NPL010092Current
U73100DL1979PTC010092Previous

Recent Activity on Dabur Research Foundation

Dabur Research Foundation has 13 board changes on record since 1981: 5 appointments and 8 cessations. The latest: Gaurav Chamaria ceased to be Additional Director on 11 Sep 2024.

AGM
Dabur Research Foundation last Annual general meeting of members was held on 18 Sep 2025 as per latest MCA records.
Filing
Dabur Research Foundation has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Gaurav Chamaria ceased to be Additional Director.
Appointed
Gaurav Chamaria was appointed as Director.
Ceased
Pankaj Bhardwaj ceased to be Additional Director.
Ceased
Ajay Kumar Vij ceased to be Director.
Ceased
Rangaswamy Satyanarayana Rao Manchanahalli ceased to be Director.
Ceased
Padmanaban Govindarajan ceased to be Director.
Ceased
Rama Mukherjee ceased to be Director.
Ceased
Aditya Chand Burman ceased to be Additional Director.
Ceased
Ashok Chand Burman ceased to be Director.
Appointed
Vivek Chand Burman was appointed as Director.

4 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Dabur Research Foundation

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Dabur Research Foundation

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Dabur Research Foundation

Dabur Research Foundation has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
07AAATD2653G1ZZDelhiActive01 Jul 2017
09AAATD2653G1ZVUttar PradeshActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Dabur Research Foundation

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dabur Research Foundation

Dabur Research Foundation is an active public not for profit company based in New Delhi, Delhi, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 24 December 1979 (47+ years old) and is registered under CIN U73100DL1979NPL010092.

Dabur Research Foundation reported revenue of ₹28.06 Cr for FY 2025 (up 34% YoY).

Dabur Research Foundation has 5 current directors:

Dabur Research Foundation reported a net profit of ₹1.58 Cr (net margin 5.6%) and EBITDA of ₹5.28 Cr (EBITDA margin 18.8%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Dabur Research Foundation is 3% over three years and 6% over five years. In the latest year (FY 2025) revenue rose 34%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Dabur Research Foundation is 07AAATD2653G1ZZ, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AAATD2653G1ZV (Uttar Pradesh).

The CIN (Corporate Identification Number) of Dabur Research Foundation is U73100DL1979NPL010092. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dabur Research Foundation was incorporated on 24 December 1979, making it 47+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Dabur Research Foundation by revenue are FTF Pharma Private Limited, Clinical Research Network India Private Limited, Advity Research Private Limited, Lifeline Services Private Limited, Xellia Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Contract Research).

Gaurav Chamaria ceased to be Additional Director on 11 Sep 2024. Gaurav Chamaria was appointed as Director on 15 Dec 2023. Pankaj Bhardwaj ceased to be Additional Director on 30 Sep 2019. Dabur Research Foundation has 13 board changes on record in total.

Dabur Research Foundation has 11 MSME Form 1 returns on record between 2020 and 2023, listing 1,188 overdue payments to 53 micro and small suppliers. The latest return was filed on 04 Dec 2023.

Dabur Research Foundation can be reached through the website daburresearch.in. Its registered office is in New Delhi, Delhi, India.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available